MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-06-30, ADAP has $130,633K in assets. $201,591K in debts. $26,061K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
151.64%
Quick Ratio
129.49%
Cash Ratio
50.59%
Debt to Asset Ratio
154.32%
Assets Breakdown
    • Other current assets and prepaid...
    • Property, plant and equipment, n...
    • Cash and cash equivalents
    • Others
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid in capital
    • Deferred revenue, non-current
    • Others

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Balance Sheets
2025-06-30
Inventory, net
11,411
Other current assets and prepaid expenses
31,330
Cash and cash equivalents
26,061
Marketable securities - available-for-sale debt securities (amortized cost of 0 and 60,451) net of allowance for expected credit losses of 0 and 0
0
Accounts receivable, net of allowance for expected credit losses of 0 and 0
9,313
Total current assets
78,115
Restricted cash
1,717
Property, plant and equipment, net of accumulated depreciation of 75,028 and 51,893
28,152
Other non-current assets
94
Operating lease right-of-use assets, net of accumulated amortization of 20,721 and 17,750
18,748
Intangible assets, net of accumulated amortization of 6,141 and 5,567
3,807
Total assets
130,633
Restructuring provision
2,355
Accrued expenses and other current liabilities
24,526
Operating lease liabilities, current
4,514
Deferred revenue, current
10,700
Accounts payable
9,418
Total current liabilities
51,513
Other liabilities, non-current
4,493
Operating lease liabilities, non-current
18,491
Borrowings, non-current
25,675
Deferred revenue, non-current
101,419
Total liabilities
201,591
Accumulated deficit
-1,171,911
Common stock - ordinary shares par value 0.001, 2,108,130,546 authorized and 1,590,309,546 issued and outstanding (2024 2,039,252,874 authorized and 1,535,653,620 issued and outstanding)
2,156
Additional paid in capital
1,109,409
Accumulated other comprehensive loss
-10,612
Total stockholders' equity
-70,958
Total liabilities and stockholders' equity
130,633
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Accounts receivable, netof allowance for...$9,313K Cash and cashequivalents$26,061K Other current assetsand prepaid...$31,330K Inventory, net$11,411K Intangible assets, net ofaccumulated amortization of...$3,807K Operating leaseright-of-use assets, net of...$18,748K Other non-currentassets$94K Property, plant andequipment, net of...$28,152K Restricted cash$1,717K Total current assets$78,115K Total assets$130,633K Accumulated othercomprehensive loss-$10,612K Accumulated deficit-$1,171,911K Total liabilities andstockholders' equity$130,633K Total stockholders'equity-$70,958K Additional paid in capital$1,109,409K Common stock - ordinaryshares par value 0.001,...$2,156K Total liabilities$201,591K Deferred revenue,non-current$101,419K Borrowings, non-current$25,675K Operating leaseliabilities, non-current$18,491K Other liabilities,non-current$4,493K Total currentliabilities$51,513K Accounts payable$9,418K Deferred revenue,current$10,700K Operating leaseliabilities, current$4,514K Accrued expenses andother current...$24,526K Restructuring provision$2,355K

Adaptimmune Therapeutics PLC (ADAP)

Adaptimmune Therapeutics PLC (ADAP)